|
|
Volumn 102, Issue 7, 2010, Pages 453-455
|
|
New studies support case for bisphosphonates as possible chemopreventive agent.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
ESTROGEN RECEPTOR;
TAMOXIFEN;
BONE DENSITY;
BONE NECROSIS;
BONE TUMOR;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
EPIDEMIOLOGY;
FEMALE;
HUMAN;
INCIDENCE;
ISRAEL;
LEGAL LIABILITY;
MANDIBLE;
METABOLISM;
METASTASIS;
NOTE;
PAGET NIPPLE DISEASE;
PATHOLOGY;
POSTMENOPAUSE;
UNITED STATES;
ANTICARCINOGENIC AGENTS;
BONE DENSITY;
BONE NEOPLASMS;
BREAST NEOPLASMS;
CALIFORNIA;
CARCINOMA, DUCTAL, BREAST;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
DIPHOSPHONATES;
FEMALE;
HUMANS;
INCIDENCE;
ISRAEL;
LIABILITY, LEGAL;
MANDIBLE;
OSTEONECROSIS;
POSTMENOPAUSE;
RECEPTORS, ESTROGEN;
TAMOXIFEN;
|
|
EID: 77950553733
PISSN: None
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/djq114 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|
